Registration
BALLARD PARTNERS for JUBILANT PHARMA HOLDINGS INC.
Firm
Income
—
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Trade/USMCA renegotiations; Domestic investment
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN BALLARD New | — |
| HUNTER MORGEN New | Policy Advisor, Office of Policy Planning, U.S. State Dept. (2017); Deputy Director, Office of Trade & Manufacturing Policy, WH (2017-2018); Special Assistant to the President, Office of the Senior Advisor for Policy, WH (2018-2020) |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| JUBILANT PHARMOVA (INDIRECT) | India | India | 100.0% | — |
| JUBILANT BHARTIA GROUP (INDIRECT) | India | India | 47.7% | — |
| JUBILANT PHARMA, LTD. (DIRECT) | Singapore | Singapore | 84.7% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.